Academic Journal
POSTER: CT-356 Idecabtagene Vicleucel (ide-cel) Versus Standard Regimens in Patients With Triple-Class–Exposed (TCE) Relapsed and Refractory Multiple Myeloma (RRMM): KarMMa-3, a Phase III Randomized Controlled Trial (RCT)
العنوان: | POSTER: CT-356 Idecabtagene Vicleucel (ide-cel) Versus Standard Regimens in Patients With Triple-Class–Exposed (TCE) Relapsed and Refractory Multiple Myeloma (RRMM): KarMMa-3, a Phase III Randomized Controlled Trial (RCT) |
---|---|
المؤلفون: | Giralt, Sergio, Ailawadhi, Sikander, Arnulf, Bertrand, Patel, Krina, Cavo, Michele, Nooka, Ajay K., Manier, Salomon, Callander, Natalie, Costa, Luciano J., Vij, Ravi, Bahlis, Nizar J., Moreau, Philippe, Solomon, Scott R., Delforge, Michel, Berdeja, Jesús, Truppel-Hartmann, Anna, Yang, Zhihong, Favre-Kontula, Linda, Wu, Fan, Piasecki, Julia, Cook, Mark, Rodríguez-Otero, Paula |
المصدر: | Clinical Lymphoma Myeloma and Leukemia ; volume 23, page S232 ; ISSN 2152-2650 |
بيانات النشر: | Elsevier BV |
سنة النشر: | 2023 |
المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
نوع الوثيقة: | article in journal/newspaper |
اللغة: | English |
DOI: | 10.1016/s2152-2650(23)00909-6 |
الاتاحة: | http://dx.doi.org/10.1016/s2152-2650(23)00909-6 https://api.elsevier.com/content/article/PII:S2152265023009096?httpAccept=text/xml https://api.elsevier.com/content/article/PII:S2152265023009096?httpAccept=text/plain |
Rights: | https://www.elsevier.com/tdm/userlicense/1.0/ |
رقم الانضمام: | edsbas.68DEC8FB |
قاعدة البيانات: | BASE |
DOI: | 10.1016/s2152-2650(23)00909-6 |
---|